Verraes Med
ActiveVerraes Med has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €697k and a net result of €137k. Equity is growing by ~30.3% per year across the filed fiscal years. Its solvency ranks better than 92% of 16459 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
88
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability72▼-13
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €60k at 30 days acceptable
Liquidity ample (current ratio 19.9 against 8.66 in 2024; short-term debt: 4.6% and cash: 22% of total assets), and 4.6% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
95.4%
Return on assets
18.7%
Age of the figures
18 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-03-2025 was due by 31-10-2025 and was filed on 31-10-2025, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
on the day
2022
31 d late
2021
31 d late
2020
31 d late
2019
32 d late
2018
30 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-03-2026 and is due by 31-10-2026. Nothing is late today.
Companies Code · seven monthsPosition in the running window
31-03-2026 close19-09-2026 today31-10-2026 deadline
Financials · fiscal year 2025, micro schema
Equity
€697k▲ 24.4%
2024 · €561k
2018: €113k
2019: €119k
2020: €181k
2021: €293k
2022: €381k
2024: €561k
2018 → 2025
Total assets
€731k▲ 16.0%
2024 · €630k
2018: €120k
2019: €140k
2020: €234k
2021: €413k
2022: €464k
2024: €630k
2018 → 2025
Net result
€137k▼ 23.8%
2024 · €179k
2018: €5k
2019: €7k
2020: €64k
2021: €111k
2022: €100k
2024: €179k
2018 → 2025
Working capital
€632k▲ 31.2%
2024 · €482k
2018: €51k
2019: €61k
2020: €139k
2021: €235k
2022: €317k
2024: €482k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220242025Trend
Equity€181k-€293k▲ 61.6%€381k▲ 30.3%€561k▲ 47.0%€697k▲ 24.4%
Operating result€126k-€200k▲ 58.6%€204k▲ 1.9%€340k▲ 66.8%€275k▼ 19.1%
Net result€64k-€111k▲ 75.0%€100k▼ 9.9%€179k▲ 78.9%€137k▼ 23.8%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 19% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €731k
Fixed assets
€65k▼ 23.5%
Current assets
€666k▲ 22.2%
Equity and liabilities €731k
Equity
€697k▲ 24.4%
Debt
€33k▼ 51.7%
The debt ratio falls from 11.0% to 4.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€295k▼
2024 · €362k
Cash flow
€157k▼
2024 · €201k
Solvency
95.4%▲
2024 · 89.0%
Current ratio
19.90▲
2024 · 8.66
Quick ratio
19.90▲
2024 · 8.66
Debt / equity
0.05▼
2024 · 0.12
ROE
19.6%▼
2024 · 32.0%
ROA
18.7%▼
2024 · 28.5%
Interest coverage
3.55▼
2024 · 4.19
Debt
€33k▼
2024 · €69k
Debt ≤ 1 year
€33k▼
2024 · €63k
Income taxes
€57k▼
2024 · €79k
Staff costs
€19k▼
2024 · €45k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€630k€731k▲
Fixed assets21/28€85k€65k▼
Tangible fixed assets22/27€85k€65k▼
Furniture and vehicles24€32k€19k▼
Other tangible fixed assets26€46k€39k▼
Assets under construction and advance payments27€7k€7k=
Current assets29/58€545k€666k▲
Amounts receivable within one year40/41€18k€14k▼
Other amounts receivable41€18k€14k▼
Current investments50/53€300k€486k▲
Cash at bank and in hand54/58€221k€161k▼
Deferred charges and accrued income490/1€5k€5k▼
Equity and liabilities
Total equity and liabilities10/49€630k€731k▲
Equity10/15€561k€697k▲
Contributions10/11€12k€12k=
Reserves13€548k€685k▲
Non-distributable reserves130/1€2k€2k=
Reserves not available under the articles1311€2k€2k=
Distributable reserves133€546k€683k▲
Amounts payable17/49€69k€33k▼
Amounts payable after more than one year17€6k-
Financial debts170/4€6k-
Amounts payable within one year42/48€63k€33k▼
Current portion of amounts payable after more than one year42€11k€6k▼
Trade debts44€10k€10k▼
Suppliers440/4€10k€10k▼
Taxes, remuneration and social security45€40k€15k▼
Taxes450/3€30k€14k▼
Remuneration and social security454/9€10k€1k▼
Other amounts payable47/48€2k€2k▲
Income statement
Code20242025
Remuneration, social security and pensions62€45k€19k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€22k€20k▼
Other operating charges640/8€3k€1k▼
Gross operating margin9900€410k€316k▼
Operating profit (loss)9901€340k€275k▼
Financial income75/76B€5k€2k▼
Recurring financial income75€5k€2k▼
Financial charges65/66B€86k€83k▼
Recurring financial charges65€86k€83k▼
Profit (loss) for the period before taxes9903€259k€194k▼
Income taxes67/77€79k€57k▼
Profit (loss) for the period9904€179k€137k▼
Profit (loss) for the period to be appropriated9905€179k€137k▼
Appropriation of the result
Profit (loss) to be appropriated9906€179k€137k▼
Transfer to equity691/2€179k€137k▼
To other reserves6921€179k€137k▼
The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
31-10
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
31-03
Financial
Liquidity doublescurrent ratio 19.90
Current ratio from 8.66 to 19.90; short-term debt falls from €63k to €33k.
2024
31-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
31-03
Financial
Highest result since 2018net €179k ▲78.9%
Operating result €340k, net result €179k, both a record.
31-03
Financial
Equity above €500kEq €561k ▲47%
6 profitable years in a row build equity to €561k.
2023
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
31-12
Financial
Equity above €200kEq €293k ▲61.6%
4 profitable years in a row build equity to €293k.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
2020
31-12
Financial
Equity above €150kEq €181k ▲52%
3 profitable years in a row build equity to €181k.
01-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 32 days late
2019
30-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 30 days late
2018
07-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 7 days late
2017
05-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
2016
26-07
NBB filing
Annual accounts filed
fiscal year 2015 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brussel · 1 establishment unit since 2011
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Lakensestraat 1521000 BrusselGround area
1,951 m²
Building footprint
1,457 m²
Volume, LiDAR
19,397 m³
Parcel 21812N1410/00Z000, Brussels · tallest building 23.8 m, ±5 floors. Linked by address, not a title deed.
1 establishment unit
Lakensestraat 152, 1000 Brussel
since 20112.198.984.753
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21812N1410/00Z000 | Brussels | 1,951 m² | 1 · 1,457 m² | 23.8 m · 5 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Recognitions · licences · registrations
Legal Entity Identifier
549300F0TN42AFV28N87
Similar companies · same sector, comparable size
SOCIETE MEDICALE AKTAS
BE 0874.139.056
Charleroi · Eq €698k
DOKTER BOUTS VICTOR
BE 0820.834.784
Hasselt · Eq €698k
DOKTER EERENS
BE 0457.866.922
Genk · Eq €697k
Docteur Nicolas Dechamps, médecin généraliste
BE 0698.639.827
Namur · Eq €698k
Dr Wolfs T.
BE 0827.634.484
Brasschaat · Eq €697k
Of 9,120 companies in sector 86210 we hold annual accounts for 6,336. 4,578 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded28-04-2011
Fiscal year end31-03
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 14 filingsAddress and cadastre registers
Data from official sources, last processed on 19-09-2026. Scores and ratios are computed by Checked and are not a credit decision.